MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
LENSAR Long-Term Debt 2011-2026 | LNSR
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt LENSAR
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.99 M | 2.09 M | 1.75 M | 2.27 M | 2.8 M | - | 20.2 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.2 M | 1.75 M | 5.18 M |
Quarterly Long-Term Debt LENSAR
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.19 M | 1.81 M | 1.96 M | 2.09 M | 1.32 M | 1.46 M | - | 1.75 M | 1.89 M | 2.03 M | 2.17 M | 2.27 M | 2.41 M | 2.54 M | 2.67 M | 2.8 M | 2.93 M | 3.06 M | 3.19 M | 3.31 M | 3.31 M | 3.31 M | 3.31 M | 333 K | 333 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.31 M | 333 K | 2.27 M |
Long-Term Debt of other stocks in the Medical devices industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Electromed
ELMD
|
1.1 M | $ 25.52 | -0.85 % | $ 216 M |  USA |
 |
Apollo Endosurgery
APEN
|
34 M | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
12 K | $ 1.97 | -5.18 % | $ 1.2 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
71.3 M | - | - | $ 1.77 B | USA |
 |
Aziyo Biologics
AZYO
|
3.59 M | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.72 B | $ 13.01 | -2.77 % | $ 1.76 B | USA |
 |
Allied Healthcare Products
AHPI
|
2.93 K | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
11.8 M | - | -13.19 % | $ 166 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
7.56 M | - | - | $ 3.31 B | USA |
 |
Pulmonx Corporation
LUNG
|
37 M | $ 1.22 | -0.45 % | $ 49.6 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
430 K | - | -5.86 % | $ 30.6 M | USA |
 |
Orthofix Medical
OFIX
|
157 M | $ 11.67 | -2.02 % | $ 462 M |  Curacao |
 |
EDAP TMS S.A.
EDAP
|
2.16 M | $ 3.43 | 4.57 % | $ 128 M |  France |
 |
Conformis
CFMS
|
20.6 M | - | - | $ 16.4 M | USA |
 |
Insulet Corporation
PODD
|
931 M | $ 178.73 | -2.26 % | $ 12.6 B | USA |
 |
Cardiovascular Systems
CSII
|
1.33 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
16.7 M | $ 0.62 | 3.33 % | $ 38.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
49.1 M | $ 10.52 | -5.05 % | $ 298 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.11 M | - | 14.99 % | $ 929 K | USA |
 |
Globus Medical
GMED
|
436 K | $ 89.25 | -1.61 % | $ 12.1 B | USA |
 |
Sintx Technologies
SINT
|
2.84 M | $ 2.1 | -2.33 % | $ 5.82 M | USA |
 |
Eargo
EAR
|
11.9 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
290 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
17.1 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
1.65 M | - | -0.57 % | $ 7.12 M | USA |
 |
TELA Bio
TELA
|
55.7 M | $ 0.77 | -0.83 % | $ 36.1 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
154 K | - | 0.03 % | $ 1.58 B |  Israel |
 |
TransMedics Group
TMDX
|
453 M | $ 100.9 | -0.36 % | $ 3.43 B | USA |
 |
Tandem Diabetes Care
TNDM
|
310 M | $ 18.19 | -2.36 % | $ 1.24 B | USA |
 |
Misonix, Inc.
MSON
|
38.6 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
7.64 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
20.4 M | $ 4.92 | -4.65 % | $ 1.04 B | USA |
 |
Intersect ENT, Inc.
XENT
|
63.6 M | - | - | $ 955 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
99.8 M | $ 15.09 | -0.33 % | $ 354 M | USA |
 |
Delcath Systems
DCTH
|
835 K | $ 10.31 | -2.27 % | $ 369 M | USA |
 |
Varex Imaging Corporation
VREX
|
366 M | $ 11.47 | -4.97 % | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
98 K | $ 1.04 | - | $ 17.6 M | USA |
 |
Vivos Therapeutics
VVOS
|
469 K | $ 0.81 | -4.1 % | $ 8.32 M | USA |
 |
CONMED Corporation
CNMD
|
834 M | $ 36.03 | -2.07 % | $ 1.12 B | USA |
 |
LivaNova PLC
LIVN
|
345 M | $ 59.54 | -2.86 % | $ 3.25 B |  Britain |
 |
Inspire Medical Systems
INSP
|
30 M | $ 53.69 | -2.58 % | $ 1.58 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.19 B | $ 84.0 | -0.76 % | $ 2.92 B | USA |
 |
Invacare Corporation
IVC
|
354 M | - | - | $ 24.7 M | USA |